BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29415504)

  • 1. Fundamental Molecules and Mechanisms for Forming and Maintaining Neuromuscular Synapses.
    Burden SJ; Huijbers MG; Remedio L
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural agrin increases postsynaptic ACh receptor packing by elevating rapsyn protein at the mouse neuromuscular synapse.
    Brockhausen J; Cole RN; Gervásio OL; Ngo ST; Noakes PG; Phillips WD
    Dev Neurobiol; 2008 Aug; 68(9):1153-69. PubMed ID: 18506821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
    Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms underlying the formation of neuromuscular junction].
    Higuchi O; Yamanashi Y
    Brain Nerve; 2011 Jul; 63(7):649-55. PubMed ID: 21747134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MuSK in synapse formation and neuromuscular disease.
    Burden SJ; Yumoto N; Zhang W
    Cold Spring Harb Perspect Biol; 2013 May; 5(5):a009167. PubMed ID: 23637281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Dok-7 in skeletal muscle enhances neuromuscular transmission with structural alterations of neuromuscular junctions: Implications in robustness of neuromuscular transmission.
    Eguchi T; Tezuka T; Fukudome T; Watanabe Y; Sagara H; Yamanashi Y
    Biochem Biophys Res Commun; 2020 Feb; 523(1):214-219. PubMed ID: 31848047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The extracellular region of Lrp4 is sufficient to mediate neuromuscular synapse formation.
    Gomez AM; Burden SJ
    Dev Dyn; 2011 Dec; 240(12):2626-33. PubMed ID: 22038977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building, Breaking, and Repairing Neuromuscular Synapses.
    Herbst R; Huijbers MG; Oury J; Burden SJ
    Cold Spring Harb Perspect Biol; 2024 May; 16(5):. PubMed ID: 38697654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The muscle protein Dok-7 is essential for neuromuscular synaptogenesis.
    Okada K; Inoue A; Okada M; Murata Y; Kakuta S; Jigami T; Kubo S; Shiraishi H; Eguchi K; Motomura M; Akiyama T; Iwakura Y; Higuchi O; Yamanashi Y
    Science; 2006 Jun; 312(5781):1802-5. PubMed ID: 16794080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AChRs Are Essential for the Targeting of Rapsyn to the Postsynaptic Membrane of NMJs in Living Mice.
    Chen PJ; Martinez-Pena Y Valenzuela I; Aittaleb M; Akaaboune M
    J Neurosci; 2016 May; 36(21):5680-5. PubMed ID: 27225759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lrp4 is a receptor for Agrin and forms a complex with MuSK.
    Kim N; Stiegler AL; Cameron TO; Hallock PT; Gomez AM; Huang JH; Hubbard SR; Dustin ML; Burden SJ
    Cell; 2008 Oct; 135(2):334-42. PubMed ID: 18848351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders.
    Ohno K; Ohkawara B; Ito M
    Expert Opin Ther Targets; 2017 Oct; 21(10):949-958. PubMed ID: 28825343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses.
    Oury J; Liu Y; Töpf A; Todorovic S; Hoedt E; Preethish-Kumar V; Neubert TA; Lin W; Lochmüller H; Burden SJ
    J Cell Biol; 2019 May; 218(5):1686-1705. PubMed ID: 30842214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis.
    Yan M; Xing GL; Xiong WC; Mei L
    Ann N Y Acad Sci; 2018 Feb; 1413(1):126-135. PubMed ID: 29377176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse.
    Lin W; Burgess RW; Dominguez B; Pfaff SL; Sanes JR; Lee KF
    Nature; 2001 Apr; 410(6832):1057-64. PubMed ID: 11323662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diseases of the neuromuscular junction.
    McConville J; Vincent A
    Curr Opin Pharmacol; 2002 Jun; 2(3):296-301. PubMed ID: 12020474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
    Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
    Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of agrin isoforms in Xenopus embryos alters the distribution of synaptic acetylcholine receptors during development of the neuromuscular junction.
    Godfrey EW; Roe J; Heathcote RD
    Dev Biol; 1999 Jan; 205(1):22-32. PubMed ID: 9882495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the neuromuscular junction.
    Witzemann V
    Cell Tissue Res; 2006 Nov; 326(2):263-71. PubMed ID: 16819627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Anatomy of the Neuromuscular Junction in Health and Disease.
    Nishimune H; Shigemoto K
    Neurol Clin; 2018 May; 36(2):231-240. PubMed ID: 29655446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.